(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Menú Volver a Committee

DIA 2027 Global Annual Meeting

Meet the Program Committee

The Program Committee helps shape DIA 2027, bringing together expertise across the product lifecycle.

Register Today Get Involved

Comité del programa

  • Linda Akunne, MPH
    Linda Akunne, MPH • Chief, Project Management Staff, ORO, OND, CDER
    FDA, United States
  • Karthik Balasubramanian, PhD, MS
    Karthik Balasubramanian, PhD, MS • Dir Project/Program Management, External Manufacturing
    Teva Pharmaceuticals, United States
  • Amy Bertha
    Amy Bertha • Executive Director, Regulatory Policy and Science
    Bayer, United States
  • Asia Blackwell
    Asia Blackwell • Consumer Safety Officer, CBER
    FDA, United States
  • James Buchanan, PharmD
    James Buchanan, PharmD • President
    Covilance LLC, United States
  • Mandy Kaur Budwal-Jagait, MSc
    Mandy Kaur Budwal-Jagait, MSc • Interim Deputy Director Standards and Compliance
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Magda Bujar
    Magda Bujar • Associate Director, Regulatory Programme and Strategic Partnerships
    Centre for Innovation in Regulatory Science (CIRS), United Kingdom
  • Ramona Burress, PharmD
    Ramona Burress, PharmD • Board Member
    Onyx Health Collective, United States
  • Brooke Casselberry, MS, RAC
    Brooke Casselberry, MS, RAC • Vice President, Advisory and Delivery
    Epista Life Science, United States
  • Nina S. Cauchon, PhD
    Nina S. Cauchon, PhD • Director Regulatory Affairs CMC
    Amgen, United States
  • Meghana Chalasani, MHA
    Meghana Chalasani, MHA • Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
    FDA, United States
  • Joan Chambers
    Joan Chambers • Independent Senior Consultant
    Tufts Center for the Study of Drug Development, United States
  • Wendy Charles, PhD
    Wendy Charles, PhD • Associate Professor
    University of Colorado Denver, United States
  • Rachel Chasse, MS
    Rachel Chasse, MS • Associate Director, Digital Science Strategy
    AbbVie, United States
  • Monica Chiaramonte, PhD
    Monica Chiaramonte, PhD • Director, Clinical Regulatory Writing
    AstraZeneca, United States
  • Lindsay Cobbs
    Lindsay Cobbs • Founder and Principal
    Takeda, United States
  • Christine Colvis, PhD
    Christine Colvis, PhD • Director, Drug Development Partnership Programs
    National Center for Advancing Translational Sciences (NCATS), United States
  • Karen Correa, PhD
    Karen Correa, PhD • Vice President, Clinical Development Operations
    Boehringer Ingelheim, United States
  • Stephanie Crawford, PhD, MPH, MS
    Stephanie Crawford, PhD, MPH, MS • Professor Emerita - Pharmacy Systems, Outcomes and Policy
    University of Illinois Chicago Retzky College of Pharmacy, United States
  • Alysha Croker
    Alysha Croker • Director, Strategic and Horizontal Policy
    Health Canada, Canada
  • Matthew Curin, PharmD
    Matthew Curin, PharmD • Sr. Dir, Head of Program Management, Therapeutic Dermatology
    Galderma, United States
  • Nicholas Daniel, PharmD, MS
    Nicholas Daniel, PharmD, MS • Regulatory Officer, OND, CDER
    FDA, United States
  • Paul Dearden
    Paul Dearden • Head, Global Regulatory Policy
    Biogen, United Kingdom
  • Victoria DiBiaso, BSN, MPH, RN
    Victoria DiBiaso, BSN, MPH, RN • Head of Patient Driven Medicines Development, R&D
    Sanofi, France
  • Joseph Dustin
    Joseph Dustin • Senior Director Digital Clincal Development
    Sanofi, United States
  • Wyatt Gotbetter, MPA
    Wyatt Gotbetter, MPA • President, Market Access
    Fingerpaint Group, United States
  • Courtney Granville, PhD, MPH
    Courtney Granville, PhD, MPH • Founder & Lead Consultant
    Paracelsus Partners LLC, United States
  • Lani Hashimoto
    Lani Hashimoto • Consultant, Patient Experience
    Hashimoto Consulting Services, United States
  • Sabine Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Stacy Holdsworth, PharmD
    Stacy Holdsworth, PharmD • US Regulatory Policy & Strategy Consultant
    Holdsworth Solutions LLC, United States
  • Cammilla Horta Gomes, MA
    Cammilla Horta Gomes, MA • Latam Regulatory Policy Lead
    Roche, Brazil
  • Huong Huynh, PhD
    Huong Huynh, PhD • Director of Regulatory Science
    Critical Path Institute, United States
  • Sarah Jarvis, MBA
    Sarah Jarvis, MBA • Global Medical & Evidence Lead
    ZS Associates, United States
  • Angelika Joos, MPharm
    Angelika Joos, MPharm • Consultant
    Clinical Regulatory Policy International Strategy Consultant, Belgium
  • Kimberley Kallsen, PhD, MPH
    Kimberley Kallsen, PhD, MPH • Head of Patient & Site Engagement, Global Clinical Development Operations
    Boehringer Ingelheim, Germany
  • Yatika Kohli, MBA
    Yatika Kohli, MBA • Chief Compliance and Strategy Officer
    NoNO Inc, Canada
  • Dominique Lagrave, PharmD
    Dominique Lagrave, PharmD • Chief Regulatory Officer
    Accumulus Technologies, United States
  • Elizabeth Lange, MPH, MS
    Elizabeth Lange, MPH, MS • Vice President
    Novo Nordisk A/S, United States
  • Charles Lee, MBA, MS
    Charles Lee, MBA, MS • Executive Regulatory Science Director
    AstraZeneca, United States
  • Jong-Hoon Lee, MD
    Jong-Hoon Lee, MD • Senior Physician, OC, CDER
    FDA, United States
  • Demetra Macheras, MBA
    Demetra Macheras, MBA •
    United States
  • Sarah K. Martin, MS
    Sarah K. Martin, MS • Executive Director - Global Regulatory Policy & Strategy (U.S.A. & LATAM)
    Eli Lilly and Company, United States
  • Lindsay McNair, MD, MPH, MS
    Lindsay McNair, MD, MPH, MS • Principal Consultant
    Equipoise Consulting, United States
  • Pallavi Mishra-Kalyani, PhD, MS
    Pallavi Mishra-Kalyani, PhD, MS • Deputy Division Director, DBV, OB, CDER
    FDA, United States
  • May F Mo, MBA, MS
    May F Mo, MBA, MS • Associate Vice President, Biostatistics
    Amgen, United States
  • Monica Munoz, PharmD, PhD
    Monica Munoz, PharmD, PhD • Division Director, Pharmacovigilance-I, OSE, CDER
    FDA, United States
  • Y. Veronica Pei, MD, MPH
    Y. Veronica Pei, MD, MPH • Deputy Division Director
    FDA, United States
  • Vada A. Perkins, DVM, MSc, MSN
    Vada A. Perkins, DVM, MSc, MSN • Vice President, Global Head of Regulatory Intelligence & Policy
    Boehringer Ingelheim, United States
  • Regina Lynn Preciado
    Regina Lynn Preciado • Vice President, Content Strategy Solutions
    Content Rules, Inc., United States
  • Amanda Roache, MS
    Amanda Roache, MS • Deputy Vice President, Science and Regulatory Advocacy
    PhRMA, United States
  • Anjali Shah, PharmD
    Anjali Shah, PharmD • Executive Director, Business Capabilities and Innovation, WWPS
    United States
  • Cary Smithson, MBA
    Cary Smithson, MBA • Managing Partner and Owner
    LeapAhead Solutions, Inc., United States
  • Elizabeth Somers, MS
    Elizabeth Somers, MS • Associate Vice President, Global Project and Alliance Management
    Merck & Co., Inc., United States
  • Benjamin Stevens, MPH
    Benjamin Stevens, MPH • Senior Director, Regulatory Affairs CMC Policy and Advocacy
    Alnylam Pharmaceuticals, United States
  • Ling Su, PhD
    Ling Su, PhD • Research Fellow
    Yeehong Business School, China
  • John Z. Sun, MBA, PMP
    John Z. Sun, MBA, PMP • Program Lead, Portfolio, Strategy & Operations, CRM DU, Development
    Novartis, United States
  • Michael Torok, PhD
    Michael Torok, PhD • Vice President, Global Head of Quality Assurance Programs
    Genentech, A Member of the Roche Group, United States
  • Nicole Turner
    Nicole Turner • Head, Study Optimization
    Daiichi Sankyo, United States
  • Yoshiaki Uyama, PhD, MS, RPh
    Yoshiaki Uyama, PhD, MS, RPh • Executive Director, Regulatory Science Center
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Pujita Vaidya, MPH
    Pujita Vaidya, MPH • Director, Regulatory Science and Policy
    Sanofi, United States
  • James Valentine, JD, MHS
    James Valentine, JD, MHS • Director
    Hyman, Phelps & McNamara, PC, United States
  • Sarah Vaughan
    Sarah Vaughan • Head of Vigilance Operations
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • James Wabby, MHS
    James Wabby, MHS • VP, Head of Regulatory Strategy, Emerging Technologies and Combination Products
    AbbVie, United States
  • Larisa Wu, PhD, MS
    Larisa Wu, PhD, MS • Chemist, ONDP, OPQ, CDER
    FDA, United States
  • Amira Deia Younes
    Amira Deia Younes • Director- Europe, Middle East & Africa (EMEA), Science & Regulatory Policy
    MSD, United Arab Emirates
Load More
Registration Rates Back to DIA 2027 Back to DIAglobal.org

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.